believed

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Drawing Parallels

For many people in crypto, the way that regulators are approaching the industry is unique and can at times seem unnecessarily adversarial. For those with prior experience in nascent industries, it bears remarkable similarities to how other technologies have seen regulations imposed on them. For many people in crypto, the way that regulators are approaching the industry is unique and can at times seem unnecessarily adversarial. For those with prior experience in nascent industries, it bears remarkable similarities to how other technologies have seen regulations imposed on them. Five years

Bugging Out

We’re pleased to announce that from today, October 13th 2022, Paribus will be launching our bug bounty program on ImmuneFi. The program will apply to our MVP even while it’s on the public testnet and should help to provide additional confidence when we’re ready to launch on the mainnet. Bug bounty programs are a crucial aspect of the ongoing maintenance and security of DeFi protocols. There are two main types of program, formal and informal. An example of an informal bug bounty program is the identification of several security vulnerabilities